The University of Wisconsin Comprehensive Cancer Center is a matrix center that works with other departments in the medical school in planning and implementing cancer programs, fostering recruitments of key faculty, and providing space and resources for faculty in center programs. The UWCCC has as its major mission the development of fundamental knowledge and fostering interactive laboratory and clinical research. The research is aimed at improving our basic understanding of neoplastic diseases and ways to prevent the disease or improve the outcomes for patients with cancer. The cancer center programs all have a spectrum of activities that range from basic laboratory studies to clinical or control applications. The center programs reach out into 31 different departments and 7 colleges and involve 144 members. The center impacts on clinical care by fostering research in major diseases, such as urologic, breast, and pediatric cancers, or offering our patients new experimental therapies, stressing the appropriate application of pain control and emphasizing research in cancer prevention. Coordination is achieved by providing support for senior and program leaders, excellent shared services, adequate space for both clinical and lab research, a strong biostatistics and computer resource, and administrative support. The UWCCC investigators have been key players in developing many new cancer drugs, biologic response modifiers and chemoprevention agents. The basic research programs all include activities that relate to human cancers such as bladder, prostate and breast cancers, focussed on finding out why these cancers start, how to treat them or prevent their occurrence. Recently an increasing emphasis has been on prevention. UW investigators have been in the forefront of prevention research with the introduction and safety testing of tamoxifen as a chemopreventive agent for breast cancer. The UWCCC impacts on clinical research in the community through a variety of mechanisms. These include the affiliate programs of ECOG and the regional council of cancer organizations who work through the council to implement cancer control research. The UWCCC collaborates with the state Division of Health developing statewide programs in pain control, smoking cessation, tumor reporting, and breast screening. UWCCC intends to strengthen its current fundamental research efforts. The disciplines of nursing and surgical oncology require nurturing. The UWCCC sees prevention as an important area of expanded effort The UWCCC will continue to look for strategies in the lab and take these to the clinic. The CCSG proposal requests support for these current and developmental research thrusts, the program leaders and essential research shared resources.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014520-23
Application #
2086256
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1976-01-01
Project End
1998-03-31
Budget Start
1995-04-01
Budget End
1996-03-31
Support Year
23
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Wargowski, Ellen; Johnson, Laura E; Eickhoff, Jens C et al. (2018) Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine. J Immunother Cancer 6:21
Bednarz, Bryan; Grudzinski, Joseph; Marsh, Ian et al. (2018) Murine-specific Internal Dosimetry for Preclinical Investigations of Imaging and Therapeutic Agents. Health Phys 114:450-459
Romero-Masters, James C; Ohashi, Makoto; Djavadian, Reza et al. (2018) An EBNA3C-deleted Epstein-Barr virus (EBV) mutant causes B-cell lymphomas with delayed onset in a cord blood-humanized mouse model. PLoS Pathog 14:e1007221
Xu, Cheng; Chen, Feng; Valdovinos, Hector F et al. (2018) Bacteria-like mesoporous silica-coated gold nanorods for positron emission tomography and photoacoustic imaging-guided chemo-photothermal combined therapy. Biomaterials 165:56-65
Lu, Zhanping; Hong, Courtney C; Kong, Guangyao et al. (2018) Polycomb Group Protein YY1 Is an Essential Regulator of Hematopoietic Stem Cell Quiescence. Cell Rep 22:1545-1559
Shea, Michael P; O'Leary, Kathleen A; Fakhraldeen, Saja A et al. (2018) Antiestrogen Therapy Increases Plasticity and Cancer Stemness of Prolactin-Induced ER?+ Mammary Carcinomas. Cancer Res 78:1672-1684
Schrager, Sarina; Burnside, Elizabeth (2018) Breast Cancer Screening in Primary Care: A Call for Development and Validation of Patient-Oriented Shared Decision-Making Tools. J Womens Health (Larchmt) :
van den Broek, Jeroen J; van Ravesteyn, Nicolien T; Mandelblatt, Jeanne S et al. (2018) Comparing CISNET Breast Cancer Incidence and Mortality Predictions to Observed Clinical Trial Results of Mammography Screening from Ages 40 to 49. Med Decis Making 38:140S-150S
Liu, Bai; Jones, Monica; Kong, Lin et al. (2018) Evaluation of the biological activities of the IL-15 superagonist complex, ALT-803, following intravenous versus subcutaneous administration in murine models. Cytokine 107:105-112
Yu, Deyang; Yang, Shany E; Miller, Blake R et al. (2018) Short-term methionine deprivation improves metabolic health via sexually dimorphic, mTORC1-independent mechanisms. FASEB J 32:3471-3482

Showing the most recent 10 out of 1528 publications